ArticleTherapeutic advances in medical oncology2023

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb).

Ran Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.